{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:53:25Z","timestamp":1790891605075,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T00:00:00Z","timestamp":1248739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Microbiology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Cell division and cell wall biosynthesis in prokaryotes are driven by partially overlapping multiprotein machineries whose activities are tightly controlled and co\u2010ordinated. So far, a number of protein components have been identified and acknowledged as essential for both fundamental cellular processes. Genes for enzymes of both machineries have been found in the genomes of the cell wall\u2010less genera <jats:italic>Chlamydia<\/jats:italic> and <jats:italic>Wolbachia<\/jats:italic>, raising questions as to the functionality of the lipid II biosynthesis pathway and reasons for its conservation. We provide evidence on three levels that the lipid II biosynthesis pathway is indeed functional and essential in both genera: (i) fosfomycin, an inhibitor of MurA, catalysing the initial reaction in lipid II biosynthesis, has a detrimental effect on growth of <jats:italic>Wolbachia<\/jats:italic> cells; (ii) isolated cytoplasmic membranes from <jats:italic>Wolbachia<\/jats:italic> synthesize lipid II <jats:italic>ex vivo<\/jats:italic>; and (iii) recombinant MraY and MurG from <jats:italic>Chlamydia<\/jats:italic> and <jats:italic>Wolbachia<\/jats:italic> exhibit <jats:italic>in vitro<\/jats:italic> activity, synthesizing lipid I and lipid II respectively. We discuss the hypothesis that the necessity for maintaining lipid II biosynthesis in cell wall\u2010lacking bacteria reflects an essential role of the precursor in prokaryotic cell division. Our results also indicate that the lipid II pathway may be exploited as an antibacterial target for chlamydial and filarial infections.<\/jats:p>","DOI":"10.1111\/j.1365-2958.2009.06815.x","type":"journal-article","created":{"date-parts":[[2009,7,28]],"date-time":"2009-07-28T09:29:15Z","timestamp":1248773355000},"page":"913-923","source":"Crossref","is-referenced-by-count":70,"title":["Functional conservation of the lipid II biosynthesis pathway in the cell wall\u2010less bacteria <i>Chlamydia<\/i> and <i>Wolbachia<\/i>: why is lipid II needed?"],"prefix":"10.1111","volume":"73","author":[{"given":"Beate","family":"Henrichfreise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Nzukou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Poellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo\u2010Julian","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Moelleken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imke","family":"Wiedemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Pfarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Georg","family":"Sahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,24]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(98)00200-8"},{"key":"e_1_2_6_3_1","first-page":"425","article-title":"Determination of antibiotic susceptibility of Rickettsiae and Chlamydiae. BS\u2010C\u20101 cell cultures","volume":"8","author":"Barker L.F.","year":"1968","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(02)00158-3"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-10-2673"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2007.06.011"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.67.1.52-65.2003"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2008.05.010"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030121"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.10.2339"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.2.3.242"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1110\/ps.9.6.1045"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129818"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.22.6507-6512.2003"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328315cde7"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4768"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02095-X"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608373104"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1128\/jcm.35.3.620-623.1997","article-title":"Antigenic and molecular analyses of different Chlamydia pneumoniae strains","volume":"35","author":"Jantos C.A.","year":"1997","journal-title":"J Clin Microbiol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2005.04661.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2005.12.004"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1128\/JB.185.4.1218-1228.2003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608643103"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510693103"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.50.3.922-927.2006","article-title":"Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal","volume":"50","author":"Makepeace B.L.","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.55.1.143-190.1991"},{"key":"e_1_2_6_27_1","first-page":"87","article-title":"Why is Chlamydia sensitive to penicillin in the absence of peptidoglycan?","volume":"2","author":"Moulder J.W.","year":"1993","journal-title":"Infect Agents Dis"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020110"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04420.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01673-06"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/8.6.557"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.69.4.585-607.2005"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2004.04149.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01040-08"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5389.754"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.2007\/006312-0"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1240"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2006.05233.x"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a071800"},{"key":"e_1_2_6_40_1","first-page":"221","article-title":"Global programme to eliminate lymphatic filariasis","volume":"81","author":"WHO","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_6_41_1","first-page":"197","article-title":"Meeting of the international task force for disease eradication","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0020069"}],"container-title":["Molecular Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2958.2009.06815.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2958.2009.06815.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T03:18:04Z","timestamp":1695957484000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2958.2009.06815.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,24]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1365-2958.2009.06815.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2958.2009.06815.x","archive":["Portico"],"relation":{},"ISSN":["0950-382X","1365-2958"],"issn-type":[{"value":"0950-382X","type":"print"},{"value":"1365-2958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,24]]}}}